{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:10:41Z","timestamp":1794499841180,"version":"4.9.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.reumae.2021.09.003","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T17:27:04Z","timestamp":1647451624000},"page":"191-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis. Colombian Association of Rheumatology"],"prefix":"10.1016","volume":"18","author":[{"given":"Wilson","family":"Bautista-Molano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M.","family":"Saldarriaga-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Junca-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s R.","family":"Fern\u00e1ndez-Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Fern\u00e1ndez-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego A.","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin A.","family":"Jauregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S.","family":"Segura-Charry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Romero-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar J.","family":"Felipe-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2021.09.003_bib0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0010","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.reumae.2021.09.003_bib0015","first-page":"245","article-title":"Prevalence of rheumatic disease in Colombia according to the Colombian Rheumatology Association (COPCORD) strategy. Prevalence study of rheumatic disease in Colombian population older than 18 years","volume":"25","author":"Londo\u00f1o","year":"2018","journal-title":"Rev Colomb Reumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3899\/jrheum.170520","article-title":"Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin america: a comparative study with the general population and data from the ASAS-COMOSPA study","volume":"45","author":"Bautista-Molano","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0025","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","article-title":"Clinical history as a screening test for ankylosing spondylitis","volume":"237","author":"Calin","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.reumae.2021.09.003_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.21619","article-title":"Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria","volume":"54","author":"Rudwaleit","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2021.09.003_bib0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/ard.2008.101501","article-title":"New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0040","first-page":"195","article-title":"Caracterizaci\u00f3n de las espondiloartropat\u00edas y determinaci\u00f3n de factores de mal pron\u00f3stico en una poblaci\u00f3n de pacientes colombianos","volume":"12","author":"Londo\u00f1o","year":"2005","journal-title":"Rev Colomb Reumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0045","first-page":"80","article-title":"Espondiloartritis en el Hospital Pablo Tob\u00f3n Uribe. Descripci\u00f3n de una cohorte","volume":"17","author":"M\u00e1rquez","year":"2010","journal-title":"Rev. Colomb. Reumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0050","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10067-016-3184-2","article-title":"Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis","volume":"35","author":"Bautista-Molano","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0055","first-page":"122","article-title":"Factors associated with the decision of the rheumatologist to order sacroiliac joints magnetic resonance imaging (SI-MRI) or HLA-B27 testing in the diagnostic work-up of patients with spondyloarthritis in clinical practice","volume":"35","author":"Bautista-Molano","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1573397113666170329121552","article-title":"The frequency of HLA-B27 in a Colombian population with signs of spondyloarthritis","volume":"14","author":"Romero-Sanchez","year":"2018","journal-title":"Curr Rheumatol Rev"},{"issue":"6S","key":"10.1016\/j.reumae.2021.09.003_bib0065","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/RHU.0000000000001671","article-title":"HLA-B allele, genotype, and haplotype frequencies in a group of healthy individuals in Colombia","volume":"27","author":"Romero-S\u00e1nchez","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0075","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.reumae.2021.09.003_bib0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0090","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.reumae.2021.09.003_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0100","author":"Orden"},{"key":"10.1016\/j.reumae.2021.09.003_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0110","first-page":"112","article-title":"Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis\u20142016 update","volume":"42","author":"Duarte","year":"2017","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.reumae.2021.09.003_bib0115","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/rheumatology\/kew223","article-title":"BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics","volume":"56","author":"Hamilton","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.reumae.2021.09.003_bib0125","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3899\/jrheum.141001","article-title":"2014 Update of the Canadian Rheumatology Association\/Spondyloarthritis Research Consortium of Canada Treatment recommendations for the management of spondyloarthritis. Part II: specific management recommendations","volume":"42","author":"Rohekar","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbspin.2013.12.002","article-title":"Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis","volume":"81","author":"Wendling","year":"2014","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.reumae.2021.09.003_bib0135","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/1756-185X.13510","article-title":"2018 APLAR axial spondyloarthritis treatment recommendations","volume":"22","author":"Tam","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0145","author":"National Institute for Health and Care Excellence (UK)"},{"key":"10.1016\/j.reumae.2021.09.003_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.reuma.2019.03.010","article-title":"Recomendaciones del Colegio Mexicano de Reumatolog\u00eda para el manejo de las espondiloartritis","volume":"17","author":"Reyes-Cordero","year":"2021","journal-title":"Reumatol Cl\u00ednica"},{"key":"10.1016\/j.reumae.2021.09.003_bib0155","article-title":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica para el Tratamiento de la Espondiloartritis Axial y la Artritis Psori\u00e1sica","author":"Ca\u00f1ete Crespillo","year":"2015","journal-title":"Soc Espo\u00f1ola Reumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0160","author":"AGREE Next Steps Consortium"},{"key":"10.1016\/j.reumae.2021.09.003_bib0165","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.reumae.2021.09.003_bib0170","series-title":"Cochrane handbook for systematic reviews of interventions version 6.2","year":"2021"},{"key":"10.1016\/j.reumae.2021.09.003_bib0175","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.reumae.2021.09.003_bib0180","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.reumae.2021.09.003_bib0185","first-page":"29","article-title":"A revised tool for assessing risk of bias in randomized trials","volume":"10","author":"Higgins","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.reumae.2021.09.003_bib0190","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/14737167.2016.1246961","article-title":"How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3\/3)","volume":"16","author":"Wijnen","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.reumae.2021.09.003_bib0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jclinepi.2018.05.011","article-title":"GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences\u2014inconsistency, imprecision, and other domains","volume":"111","author":"Zhang","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0205","doi-asserted-by":"crossref","first-page":"e000825","DOI":"10.1136\/rmdopen-2018-000825","article-title":"Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care","volume":"4","author":"Poddubnyy","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.reumae.2021.09.003_bib0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/03009742.2015.1105289","article-title":"The discriminative value of inflammatory back pain in patients with persistent low back pain","volume":"45","author":"Arnbak","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0215","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10067-014-2622-2","article-title":"Performance of different criteria sets for inflammatory back pain in patients with axial spondyloarthritis with and without radiographic sacroiliitis","volume":"33","author":"Solmaz","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0220","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar3768","article-title":"A systematic critical review on MRI in spondyloarthritis","volume":"14","author":"Arnbak","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2021.09.003_bib0225","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/annrheumdis-2013-203887","article-title":"Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis?","volume":"74","author":"Weber","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0230","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3899\/jrheum.130141","article-title":"Magnetic resonance imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis","volume":"40","author":"Poddubnyy","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0235","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/annrheumdis-2017-211596","article-title":"Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0240","article-title":"Methotrexate for ankylosing spondylitis","volume":"2","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.reumae.2021.09.003_bib0245","article-title":"Sulfasalazine for ankylosing spondylitis","volume":"2014","author":"Chen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.reumae.2021.09.003_bib0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-012-2125-y","article-title":"Tramadol\/acetaminophen combination as add-on therapy in the treatment of patients with ankylosing spondylitis","volume":"32","author":"Chang","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/acr.22708","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.reumae.2021.09.003_bib0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(19)32971-X","article-title":"Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial","volume":"395","author":"Deodhar","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.reumae.2021.09.003_bib0265","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-017-3693-7","article-title":"Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis","volume":"36","author":"Ungprasert","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0270","first-page":"5270","article-title":"Secukinumab 150\u202fmg significantly improved signs and symptoms of non-radiographic axial spondyloarthritis: results from a phase 3 double-blind, randomized, placebo-controlled study","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0275","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","article-title":"Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.reumae.2021.09.003_bib0280","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","article-title":"Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0285","doi-asserted-by":"crossref","first-page":"e000592","DOI":"10.1136\/rmdopen-2017-000592","article-title":"Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2","volume":"3","author":"Marzo-Ortega","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.reumae.2021.09.003_bib0290","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/annrheumdis-2016-210023","article-title":"Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study","volume":"76","author":"Sieper","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","article-title":"Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3","volume":"19","author":"Pavelka","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2021.09.003_bib0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2007.07.006","article-title":"Occupational therapy in ankylosing spondylitis: Short-term prospective study in patients treated with anti-TNF-alpha drugs","volume":"75","author":"Spadaro","year":"2008","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.reumae.2021.09.003_bib0305","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00296-017-3829-8","article-title":"The role of land and aquatic exercise in ankylosing spondylitis: a systematic review","volume":"37","author":"Z\u00e3o","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2021.09.003_bib0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0315","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.apmr.2017.07.015","article-title":"Effectiveness of exercise programs in ankylosing spondylitis: a meta-analysis of randomized controlled trials","volume":"99","author":"P\u00e9courneau","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.reumae.2021.09.003_bib0320","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.medcli.2019.04.020","article-title":"Efficacy of acupuncture in rheumatic diseases with spine involvement: systematic review [English] [Spanish]","volume":"153","author":"Nishishinya Aquino","year":"2019","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.reumae.2021.09.003_bib0325","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000442733","article-title":"Akupunktur versus krankheitsmodifizierende Antirheumatika in der Behandlung der ankylosierenden Spondylitis \u2014 eine Metaanalyse","volume":"22","author":"Lv","year":"2015","journal-title":"Complement Med Res"},{"key":"10.1016\/j.reumae.2021.09.003_bib0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s003930050016","article-title":"Akupunktur bei der Behandlung entz\u00fcndlich-rheumatischer Erkrankungen (Acupuncture in treatment of inflammatory rheumatoid diseases)","volume":"56","author":"Lautenschl\u00e4ger","year":"1997","journal-title":"Zeitschrift fur Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0335","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jbmt.2017.04.008","article-title":"Is Pilates an effective rehabilitation tool? A systematic review","volume":"22","author":"Byrnes","year":"2018","journal-title":"J Bodyw Mov Ther"},{"key":"10.1016\/j.reumae.2021.09.003_bib0340","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/1980-5918.029.003.AO19","article-title":"The Pilates method in the rehabilitation of musculoskeletal disorders: a systematic review","volume":"29","author":"Cruz","year":"2016","journal-title":"Fisioter em Mov"},{"key":"10.1016\/j.reumae.2021.09.003_bib0345","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1089\/acm.2018.0405","article-title":"One year of pilates training for ankylosing spondylitis: a pilot study","volume":"25","author":"Rodr\u00edguez-L\u00f3pez","year":"2019","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.reumae.2021.09.003_bib0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00296-013-2869-y","article-title":"Effects of Pilates, McKenzie and Heckscher training on disease activity, spinal motility and pulmonary function in patients with ankylosing spondylitis: a randomized controlled trial","volume":"34","author":"Ro\u015fu","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2021.09.003_bib0355","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00296-011-1932-9","article-title":"Effect of Pilates training on people with ankylosing spondylitis","volume":"32","author":"Altan","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2021.09.003_bib0360","doi-asserted-by":"crossref","first-page":"e11265","DOI":"10.1097\/MD.0000000000011265","article-title":"A retrospective study of transcutaneous electrical nerve stimulation for chronic pain following ankylosing spondylitis","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reumae.2021.09.003_bib0365","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00296-017-3867-2","article-title":"The efficacy of tai chi and yoga in rheumatoid arthritis and spondyloarthropathies: a narrative biomedical review","volume":"38","author":"Akyuz","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2021.09.003_bib0370","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/1756-185X.13735","article-title":"Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore","volume":"22","author":"Kwan","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reumae.2021.09.003_bib0375","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00296-014-3168-y","article-title":"Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study","volume":"35","author":"Kilic","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2021.09.003_bib0380","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10067-014-2729-5","article-title":"Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?","volume":"33","author":"Au","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.09.003_bib0385","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00296-017-3814-2","article-title":"Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study)","volume":"37","author":"Sellas i Fernandez","year":"2017","journal-title":"Rheumatol Int"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:02:14Z","timestamp":1761879734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574322000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2173574322000430"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2021.09.003","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis. Colombian Association of Rheumatology","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2021.09.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}